W.K. Alfred Yung - Concepedia

Author

W.K. Alfred Yung

The University of Texas MD Anderson Cancer Center

Also Known As

A. Rademaker, Adelheid Woehrer, Carlos Kamiya-Matsuoka, Christine Jungk, Jichun Xie, R. J. Diaz, Steck, W K Alfred Yung, W K Yung, W Yung

263

Publications

21.7K

Citations

H-Index

124

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of California, San Francisco Neurological Surgery Dana-Farber Cancer Institute University of California, Los Angeles

About

W.K. Alfred Yung is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	78	9.2K
2	Health Sciences	19	23	1.1K
3	Education	1	1	109
4	Engineering	1	1	109
5	Natural Sciences	1	1	62

W.K. Alfred Yung

150

Publications

19.3K

Citations

H-Index

Page 1

	Year	Citations
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Peter A. Steck, Mark A. Pershouse, Samar A. Jasser, Nature Genetics Multiple Advanced CancersTumor BiologyChromosome 10Q23.3OncologyMedicine	1997	2.8K
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Journal of Clinical Oncology	2009	2.4K
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis Nu Zhang, Ping Wei, Aihua Gong, Cancer Cell Tumor BiologyTranscriptional RegulationSignaling PathwayGliomaMedicine	2011	576
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Dahong Teng, Rong Hu, Huai Lin, PubMed GeneticsPathologyCancer BiologyGliomaTumor Biology	1997	471
Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results Frederick F. Lang, Janet M. Bruner, Gregory N. Fuller, Journal of Clinical Oncology	2003	391
Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors Igor Vivanco, H. Ian Robins, Daniel Rohle, Cancer Discovery	2012	336
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires David Osoba, Neil K. Aaronson, Martin J. Muller, Quality of Life Research Quality Of LifeNeuro-oncologyPsychometric ValidationLife AssessmentPsychiatry	1996	335
Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma Janice Nigro, Anjan Misra, Li Zhang, Cancer Research	2005	324
Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma Christopher E. Pelloski, Karla V. Ballman, Alfred Furth, Journal of Clinical Oncology	2007	307
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy Jeffery J. Raizer, L. E. Abrey, Andrew B. Lassman, Neuro-Oncology PharmacotherapyHigh-grade GliomasGliomaNeuro-oncologyOncology	2009	294

Page 1